...
首页> 外文期刊>Inflammopharmacology >Ponicidin inhibits pro-inflammatory cytokine TNF--induced epithelial-mesenchymal transition and metastasis of colorectal cancer cells via suppressing the AKT/GSK-3/Snail pathway
【24h】

Ponicidin inhibits pro-inflammatory cytokine TNF--induced epithelial-mesenchymal transition and metastasis of colorectal cancer cells via suppressing the AKT/GSK-3/Snail pathway

机译:通过抑制AKT / GSK-3 /蜗牛途径,Ponicidin抑制促炎细胞因子TNF诱导的结直肠癌细胞的转移癌细胞转变和转移

获取原文
获取原文并翻译 | 示例
           

摘要

Ponicidin (PON), a natural diterpenoid compound, has been shown to exhibit potent anticancer activities in a wide variety of cancers, including colorectal cancer (CRC). Nevertheless, the precise mechanisms underlying the anti-metastasis effect of PON have not yet been completely defined. The present study was designed to uncover the inhibitory effect of PON on epithelial-mesenchymal transition (EMT), migration and invasion of HCT116 cells induced by pro-inflammatory cytokine tumor necrosis factor- (TNF-) in vitro, and liver metastasis in vivo. Briefly, cell proliferation was assessed by Cell Counting Kit-8 assay, followed by wound healing and transwell assays to evaluate cell migration and invasion. The EMT-related molecular markers were determined through quantitative real-time polymerase chain reaction (qPCR), immunofluorescence(IF), western blot (WB), and immunohistochemistry(IHC). Additionally, WB was used to assess the expression of AKT, phosphorylated AKT (p-AKT), GSK-3, and phosphorylated GSK-3 (p-GSK-3). As a result, PON could effectively suppress EMT, migration, and invasion in HCT116 cells in vitro, and liver metastasis of HCT116 cells in vivo. Additionally, PON administration also dramatically altered the expression of EMT-associated markers such as E-cadherin, N-cadherin, and Vimentin, and suppressed the expression of p-AKT, p-GSK-3 and transcription factor, Snail in a dose-dependent manner. Moreover, the incidence of liver metastasis in the control group was 100% and although the incidence of liver metastasis did not decrease, the number of metastatic nodules in the livers of each PON dose group decreased by (34 +/- 4.2)%, (64 +/- 3.6)%, and (76 +/- 5.3)%, respectively, compared to the control group. Collectively, these findings indicated that targeting the AKT/GSK-3/Snail pathway by PON might be a promising treatment for TNF--induced EMT and metastasis of CRC.
机译:已显示皮肤蛋白(PON),一种天然的二萜类化合物,在各种癌症中表现出强抗体活性,包括结肠直肠癌(CRC)。然而,尚未完全定义PON抗转移效应的精确机制。本研究旨在揭示PON在体外促炎细胞因子肿瘤坏死因子 - (TNF-)在体内诱导的上皮 - 间充质转换(EMT),迁移和侵袭对HCT116细胞的抑制作用,以及体内肝转移。简而言之,通过细胞计数试剂盒-8测定评估细胞增殖,然后进行伤口愈合和转发测定以评估细胞迁移和侵袭。通过定量实时聚合酶链反应(QPCR),免疫荧光(IF),Western印迹(WB)和免疫组织化学(IHC)测定EMT相关的分子标记。另外,WB用于评估AKT,磷酸化AKT(P-AKT),GSK-3和磷酸化GSK-3(P-GSK-3)的表达。结果,PON可以有效地抑制在体外HCT116细胞中的EMT,迁移和侵袭,以及体内HCT116细胞的肝转移。另外,PON给药也显着改变了EMT相关标志物的表达,例如E-Cadherin,N-Cadherin和Vimentin,并抑制了P-AKT,P-GSK-3和转录因子的表达,蜗牛(Dose)依赖的方式。此外,对照组肝转移的发生率为100%,尽管肝转移的发生率没有减少,但每个PON剂量组的肝脏中的转移结节的数量减少(34 +/- 4.2)%,(与对照组相比,64 +/- 3.6)%分别为(76 +/- 5.3)%。总的来说,这些发现表明,PON的AKT / GSK-3 /蜗牛途径靶向TNF诱导的EMT和CRC转移的有希望的治疗方法。

著录项

  • 来源
    《Inflammopharmacology》 |2019年第3期|共12页
  • 作者单位

    Nanjing Univ Chinese Med Sch Med &

    Life Sci Nanjing 210023 Jiangsu Peoples R China;

    Nanjing Univ Chinese Med Sch Med &

    Life Sci Nanjing 210023 Jiangsu Peoples R China;

    Nanjing Univ Chinese Med Sch Med &

    Life Sci Nanjing 210023 Jiangsu Peoples R China;

    Nanjing Univ Chinese Med Sch Med &

    Life Sci Nanjing 210023 Jiangsu Peoples R China;

    Nanjing Univ Chinese Med Sch Med &

    Life Sci Nanjing 210023 Jiangsu Peoples R China;

    Nanjing Univ Chinese Med Sch Med &

    Life Sci Nanjing 210023 Jiangsu Peoples R China;

    Nanjing Univ Chinese Med Sch Med &

    Life Sci Nanjing 210023 Jiangsu Peoples R China;

    Nanjing Univ Chinese Med Affiliated Hosp Inst Pediat Jiangsu Key Lab Pediat Resp Dis Nanjing;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

    Ponicidin; Colorectal cancer; Tumor necrosis factor-; Epithelial-mesenchymal transition; Metastasis;

    机译:ponicidin;结肠直肠癌;肿瘤坏死因子 -;上皮 - 间充质转换;转移;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号